News Release July 17, 2007 Concerned by weaknesses in FDA's new rules for dietary supplements, ConsumerLab.com acts to "raise the bar on quality" WHITE PLAINS, NEW YORK July 17, 2007 Disappointed by the lack of quality standards within the FDA's newly released Good Manufacturing Practices (GMPs) for dietary supplements, ConsumerLab.com has announced two initiatives today intended to "raise the bar on quality
Igncio, Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression, Front
Understanding which goal aligns with your situation is the first step in any meaningful conversation with a physician
CL Answer What is the difference between CoQ10 and ubiquinol
Encouragement to make informed decisions based on skin type and condition Decisions are based on the knowledge of your skin health, history and concerns so that outcomes can be related to this
In the context of AD, where neuroinflammation and neurotoxicity are prominent pathological hallmarks, the modus operandi of NLY01 offers a potential therapeutic avenue to mitigate analogous pathological mechanisms inherent to this neurodegenerative condition
